Is Amanta Healthcare a Good Buy After Its Q1 FY27 Results?

The Amanta Healthcare share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Amanta Healthcare is a manufacturer of sterile liquid pharmaceutical products including IV fluids and ophthalmic solutions, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 69 crore, up 5.4% year on year, while profit after tax came in at Rs 3.30 crore, down 5.7% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Amanta Healthcare share price from here.

This piece works through the quarter's financial highlights, the business factors behind the numbers, where the Amanta Healthcare share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

Amanta Healthcare Q1 FY27 Financial Highlights

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 69 crore	Rs 65 crore	5.4%
EBITDA	Rs 14 crore	Rs 15 crore	-2.7%
Operating Margin	21.1%	22.8%	NA
Net Profit / (Loss)	Rs 3.30 crore	Rs 3.50 crore	-5.7%

Amanta Healthcare Q1 FY27 Performance Analysis

Check Amanta Healthcare Fundamentals on Univest Screener

Revenue growth of 5.4% for the quarter came from steady demand across the company's core business, keeping the topline trend intact for the sterile liquid pharmaceutical manufacturing sector.

Profitability is where the quarter disappointed. PAT fell 6% year on year to Rs 3.30 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Amanta Healthcare share price this quarter.

Sequential quarterly data was not fully available for this comparison, so investors should track the next quarter's results to build out the trend behind the Amanta Healthcare share price.

Key Business Factors in Q1 FY27

Revenue Trend

Amanta Healthcare's revenue grew 5.4% year on year this quarter, taking the quarterly base to Rs 69 crore in a sterile liquid pharmaceutical manufacturing business that remains sensitive to demand and pricing cycles that ultimately feed through to the Amanta Healthcare share price.

Margin Movement

EBITDA fell to Rs 14 crore from Rs 15 crore, with operating margin slipping to 21.1% from 22.8%, pointing to cost or pricing pressure that management will need to manage through the rest of FY27.

Balance Sheet Position

Amanta Healthcare's balance sheet metrics were not fully available for this quarter and should be checked against the company's official filings before making an investment decision.

Valuation Context

Amanta Healthcare does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Amanta Healthcare share price.

Dividend Details

No interim dividend was declared alongside Amanta Healthcare's Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Amanta Healthcare share price for income should watch the company's announcements around its next annual results for any dividend decision.

Amanta Healthcare Share Price Outlook for FY27

The key question for the rest of FY27 is whether Amanta Healthcare can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Amanta Healthcare share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.

A stabilising or improving margin trend in the next result would be the clearest signal that this quarter's profit decline was a temporary setback rather than the start of a longer slide for the Amanta Healthcare share price.

Amanta Healthcare Stock Performance

Download the Univest iOS App or Univest Android App to track Amanta Healthcare's live share price and get daily stock updates.

The Amanta Healthcare share price was trading around Rs 202 as results season played out in late August 2026, roughly 1.8% below its 52-week high of Rs 206 and well above its 52-week low of Rs 92.

The Amanta Healthcare share price has likely already absorbed some of this quarter's disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off.

Key Risks

Profitability Risk

The quarter's profit trend is the clearest risk here. Until Amanta Healthcare shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.

Sector and Demand Risk

As a sterile liquid pharmaceutical manufacturing business, Amanta Healthcare's results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Amanta Healthcare share price well before the next result.

Execution Risk

Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

Conclusion

Amanta Healthcare's Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 6% to Rs 3.30 crore even as revenue rose. The Amanta Healthcare share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter's numbers until the margin trend turns around.

Frequently Asked Questions on Amanta Healthcare Q1 FY27 Results

What were Amanta Healthcare's Q1 FY27 results?

Ans. Amanta Healthcare reported Q1 FY27 revenue of Rs 69 crore, up 5.4% year on year, and PAT of Rs 3.30 crore, down 5.7% year on year.

Is Amanta Healthcare a good buy after its Q1 FY27 results?

Ans. Amanta Healthcare's profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.

What is the Amanta Healthcare share price today?

Ans. The Amanta Healthcare share price was trading around Rs 202 in late August 2026, about 1.8% below its 52-week high of Rs 206 and well above its 52-week low of Rs 92.

What is Amanta Healthcare's revenue and profit for Q1 FY27?

Ans. Amanta Healthcare reported revenue of Rs 69 crore and a net profit of Rs 3.30 crore for the quarter ended June 30, 2026.

Did Amanta Healthcare declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside Amanta Healthcare's Q1 FY27 results. Investors should track the company's next annual results for any dividend announcement.

What is Amanta Healthcare's PE ratio and is it expensive?

Ans. The Amanta Healthcare share price trades at a trailing PE of 52.5x. Investors should compare this with the company's growth rate before judging value.

What are the key risks for Amanta Healthcare investors right now?

Ans. The quarter's profit trend is the clearest risk here. Until Amanta Healthcare shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

What is Amanta Healthcare's promoter shareholding?

Ans. Promoter shareholding data for Amanta Healthcare was not fully available for this quarter and should be checked on the company's official filings.